Oscar G. Segurado - Concepedia

Author

Oscar G. Segurado

Research Institute Hospital 12 de Octubre ORCID

Also Known As

Elizabeth Kozora, O G SEGURADO, O G Segurado, O. G. Segurado, O. Segurado, O.G. Segurado, OSCAR G. SEGURADO, Oscar G Segurado, Oscar G. Segurado, Oscar Segurado

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Research Institute Hospital 12 de Octubre Universidad de Alcalá Abbott Fund Ludwig-Maximilians-Universität München Comunidad de Madrid

About

Oscar G. Segurado is an author at Research Institute Hospital 12 de Octubre specializing in medicine, genetics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	426
2	Health Sciences	2	2	176
3	Public Health	2	2	59
4	Engineering	1	1	38
5	Natural Sciences	1	1	10

Oscar G. Segurado

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. Dolores J. Schendel, Bernd Gänsbacher, R. Oberneder, The Journal of Immunology	1993	160
Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment Daniel Aletaha, Julia Funovits, F. C. Breedveld, Arthritis & Rheumatism	2009	140
Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial Alan Kivitz, Steven M. Cohen, James E. Dowd, Clinical Therapeutics Pain TherapyInterventional Pain MedicineHealth SciencesPain MedicinePrefilled Syringe	2006	134
Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count Theodore Pincus, Oscar G. Segurado Annals of the Rheumatic Diseases	2005	108
Expression and function of a variant T cell receptor complex lacking CD3-gamma. Paloma Pérez‐Aciego, Balbino Alarcón, Antonio Arnaiz‐Villena, The Journal of Experimental Medicine Dil2 CellsAdaptive Immune SystemT-regulatory CellImmunologyImmunologic Mechanism	1991	69
An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. Theodore Pincus, Cecilia P. Chung, Oscar G. Segurado, PubMed	2006	63
Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. Theodore Pincus, Ingrid A. Amara, Oscar G. Segurado, PubMed	2008	58
Hemophilia A gene therapy: current and next-generation approaches Steven W. Pipe, Gil Gonen-Yaacovi, Oscar G. Segurado Expert Opinion on Biological Therapy	2021	49
Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type 11 (insulin-dependent)diabetes mellitus predictive risk markers in the Spanish population José L. Vicário, Jorge Martı́nez-Laso, Alfredo Corell, Diabetologia Dq Dna SequencesGenetic DeterminantDiabetes EpidemiologySpanish PopulationMedicine	1992	48
Cost-Effectiveness of Sequential Therapy with Tumor Necrosis Factor Antagonists in Early Rheumatoid Arthritis Andrew Davies, Mary Cifaldi, Oscar G. Segurado, The Journal of Rheumatology	2008	47

Page 1